Low glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications

Ben W R Balzer, Christie L Graham, Maria E Craig, Hiran Selvadurai, Kim C Donaghue, Jennie C Brand-Miller, Kate S Steinbeck, Ben W R Balzer, Christie L Graham, Maria E Craig, Hiran Selvadurai, Kim C Donaghue, Jennie C Brand-Miller, Kate S Steinbeck

Abstract

A systematic review was conducted to assess what is known about the effect of low glycaemic index (GI) diets on glycaemic control, weight and quality of life in youth with cystic fibrosis (CF). Eligibility criteria were systematic reviews, randomised and non-randomised trials of low GI dietary interventions in CF. Outcomes examined were glycaemic control, quality of life, anthropometry and respiratory function. Reference lists were manually searched and experts in the field were consulted. Four studies met the eligibility criteria; two were excluded because they did not include data on any of the outcomes. The remaining two were studies that examined GI secondary to any other intervention: one used GI as a factor in enteral feeds and the other incorporated low GI dietary education into its treatment methodology. There is insufficient evidence to recommend use of low GI diets in CF. Since there is evidence to support use of low GI diets in type 1, type 2 and gestational diabetes, low GI diets should be tested as an intervention for CF. The potential risks and benefits of a low GI diet in CF are discussed.

Keywords: adolescent; cystic fibrosis related diabetes; dietary intervention; glycaemic index.

Figures

Figure 1
Figure 1
Study selection process.

References

    1. Mohan K., Miller H., Dyce P., Grainger R., Hughes R., Vora J., Ledson M., Walshaw M. Mechanisms of glucose intolerance in cystic fibrosis. Diabet. Med. 2009;26:582–588.
    1. Finkelstein S.M., Wielinski C.L., Elliott G.R., Warwick W.J., Barbosa J., Wu S.C., Klein D.J. Diabetes mellitus associated with cystic fibrosis. J. Pediatr. 1988;112:373–377.
    1. Koch C., Rainisio M., Madessani U., Harms H.K., Hodson M.E., Mastella G., McKenzie S.G., Navarro J., Strandvik B. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr. Pulmonol. 2001;32:343–350.
    1. Brennan A.L., Gyi K.M., Wood D.M., Johnson J., Holliman R., Baines D.L., Philips B.J., Geddes D.M., Hodson M.E., Baker E.H. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J. Cyst. Fibros. 2007;6:101–109.
    1. Ode K.L., Frohnert B., Laguna T., Phillips J., Holme B., Regelmann W., Thomas W., Moran A. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr. Diabetes. 2010;11:487–492.
    1. Sterescu A.E., Rhodes B., Jackson R., Dupuis A., Hanna A., Wilson D.C., Tullis E., Pencharz P.B. Natural history of glucose intolerance in patients with cystic fibrosis: Ten-year prospective observation program. J. Pediatr. 2010;156:613–617.
    1. Bismuth E., Laborde K., Taupin P., Velho G., Ribault V., Jennane F., Grasset E., Sermet I., de Blic J., Lenoir G., et al. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J. Pediatr. 2008;152:540–545. doi: 10.1016/j.jpeds.2007.09.025.
    1. Chamnan P., Shine B.S., Haworth C.S., Bilton D., Adler A.I. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care. 2010;33:311–316.
    1. Tofe S., Moreno J.C., Maiz L., Alonso M., Escobar H., Barrio R. Insulin-Secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur. J. Endocrinol. 2005;152:241–247.
    1. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., Lavoie A., Levesque R., Perrier J., Poisson D., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J. Cyst. Fibros. 2007;6:376–383.
    1. Moran A. Abnormal glucose tolerance in CF-when should we offer diabetes treatment? Pediatr. Diabetes. 2009;10:159–161. doi: 10.1111/j.1399-5448.2009.00521.x.
    1. Laguna T.A., Nathan B.M., Moran A. Managing diabetes in cystic fibrosis. Diabetes Obes. Metab. 2010;12:858–864.
    1. Rana M., Munns C.F., Selvadurai H., Donaghue K.C., Craig M.E. Cystic fibrosis-related diabetes in children—gaps in the evidence? Nat. Rev. Endocrinol. 2010;6:371–378. doi: 10.1038/nrendo.2010.85.
    1. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130–1139.
    1. Amiel S.A., Sherwin R.S., Simonson D.C., Lauritano A.A., Tamborlane W.V. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N. Engl. J. Med. 1986;315:215–219.
    1. Ball G.D., Huang T.T., Gower B.A., Cruz M.L., Shaibi G.Q., Weigensberg M.J., Goran M.I. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J. Pediatr. 2006;148:16–22. doi: 10.1016/j.jpeds.2005.08.059.
    1. Hannon T.S., Janosky J., Arslanian S.A. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr. Res. 2006;60:759–763.
    1. Moran A., Jacobs D.R., Jr., Steinberger J., Hong C.P., Prineas R., Luepker R., Sinaiko A.R. Insulin resistance during puberty: Results from clamp studies in 357 children. Diabetes. 1999;48:2039–2044.
    1. Vanderwel M., Hardin D.S. Growth hormone normalizes pubertal onset in children with cystic fibrosis. J. Pediatr. Endocrinol. Metab. 2006;19:237–244.
    1. Moran A., Brunzell C., Cohen R.C., Katz M., Marshall B.C., Onady G., Robinson K.A., Sabadosa K.A., Stecenko A., Slovis B. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33:2697–2708.
    1. Mozzillo E., Franzese A., Valerio G., Sepe A., De Simone I., Mazzarella G., Ferri P., Raia V. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatr. Diabetes. 2009;10:162–167.
    1. White H., Pollard K., Etherington C., Clifton I., Morton A.M., Owen D., Conway S.P., Peckham D.G. Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention. J. Cyst. Fibros. 2009;8:179–185.
    1. Thomas D., Elliott E.J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst. Rev. 2009
    1. American Diabetes Association Standards of medical care in diabetes—2011. Diabetes Care. 2011;34(Suppl. 1):S11–S61. doi: 10.2337/dc11-S011.
    1. Craig M., Twigg S., Donaghue K., Cheung N., Cameron F., Conn J., Jenkins A., Silink M., Australian Type 1 Diabetes Guidelines Expert Advisory Group . Draft National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults. Australian Government Department of Health and Ageing; Canberra, Australia: 2011.
    1. Thomas D.E., Elliott E.J. The use of low-glycaemic index diets in diabetes control. Br. J. Nutr. 2010;104:797–802.
    1. Skopnik H., Kentrup H., Kusenbach G., Pfaffle R., Kock R. Glucose homeostasis in cystic fibrosis. Oral glucose tolerance test in comparison with formula administration (in German) Monatsschr. Kinderheilkd. 1993;141:42–47.
    1. Ntimbane T., Krishnamoorthy P., Huot C., Legault L., Jacob S.V., Brunet S., Levy E., Gueraud F., Lands L.C., Comte B. Oxidative stress and cystic fibrosis-related diabetes: A pilot study in children. J. Cyst. Fibros. 2008;7:373–384.
    1. Solomon T.P., Haus J.M., Kelly K.R., Cook M.D., Filion J., Rocco M., Kashyap S.R., Watanabe R.M., Barkoukis H., Kirwan J.P. A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am. J. Clin. Nutr. 2010;92:1359–1368. doi: 10.3945/ajcn.2010.29771.
    1. Giacco R., Parillo M., Rivellese A.A., Lasorella G., Giacco A., D’Episcopo L., Riccardi G. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care. 2000;23:1461–1466.
    1. O’Sullivan T.A., Lyons-Wall P., Bremner A.P., Ambrosini G.L., Huang R.C., Beilin L.J., Mori T.A., Blair E., Oddy W.H. Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: Comparison of different metabolic syndrome definitions. Diabet. Med. 2010;27:770–778.
    1. Gellar L., Nansel T.R. High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance. J. Pediatr. 2009;154:455–458.
    1. Salmeron J., Manson J.E., Stampfer M.J., Colditz G.A., Wing A.L., Willett W.C. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277:472–477.
    1. Brand-Miller J., Dickinson S., Barclay A., Celermajer D. The glycemic index and cardiovascular disease risk. Curr. Atheroscler. Rep. 2007;9:479–485.
    1. Pawlak D.B., Kushner J.A., Ludwig D.S. Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet. 2004;364:778–785. doi: 10.1016/S0140-6736(04)16937-7.
    1. Brand-Miller J.C. Glycemic load and chronic disease. Nutr. Rev. 2003;61:S49–S55.
    1. Moses R.G., Barker M., Winter M., Petocz P., Brand-Miller J.C. Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial. Diabetes Care. 2009;32:996–1000.
    1. Larsen T.M., Dalskov S.M., van Baak M., Jebb S.A., Papadaki A., Pfeiffer A.F., Martinez J.A., Handjieva-Darlenska T., Kunesova M., Pihlsgard M., et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N. Engl. J. Med. 2010;363:2102–2113.
    1. Papadaki A., Linardakis M., Larsen T.M., van Baak M.A., Lindroos A.K., Pfeiffer A.F., Martinez J.A., Handjieva-Darlenska T., Kunesova M., Holst C., et al. The effect of protein and glycemic index on children’s body composition: the DiOGenes randomized study. Pediatrics. 2010;126:1143–1152.
    1. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 1990;13:610–630.
    1. Kitabchi A.E., Temprosa M., Knowler W.C., Kahn S.E., Fowler S.E., Haffner S.M., Andres R., Saudek C., Edelstein S.L., Arakaki R., et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: Effects of lifestyle intervention and metformin. Diabetes. 2005;54:2404–2414.
    1. Iannucci A., Mukai K., Johnson D., Burke B. Endocrine pancreas in cystic fibrosis: An immunohistochemical study. Hum. Pathol. 1984;15:278–284.
    1. Dobson L., Sheldon C.D., Hattersley A.T. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet. Med. 2004;21:691–696.
    1. O’Riordan S.M., Hindmarsh P., Hill N.R., Matthews D.R., George S., Greally P., Canny G., Slattery D., Murphy N., Roche E., et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: A prospective cohort study. Diabetes Care. 2009;32:1020–1022.
    1. Schiaffini R., Brufani C., Russo B., Fintini D., Migliaccio A., Pecorelli L., Bizzarri C., Lucidi V., Cappa M. Abnormal glucose tolerance in children with cystic fibrosis: The predictive role of continuous glucose monitoring system. Eur. J. Endocrinol. 2010;162:705–710.
    1. Franzese A., Valerio G., Buono P., Spagnuolo M.I., Sepe A., Mozzillo E., De Simone I., Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J. Pediatr. Endocrinol. Metab. 2008;21:109–116.
    1. Jefferies C., Solomon M., Perlman K., Sweezey N., Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J. Pediatr. 2005;147:396–398.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner